Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2005
12/21/2005EP1606264A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
12/21/2005EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity
12/21/2005EP1605936A1 Aryl spirohydantoin cgrp receptor antagonists
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation
12/21/2005CN1711249A Quinazolinone derivatives useful as anti-hyperalgesic agents
12/21/2005CN1709870A Optical-purity N',N'-dibasic prolyl hydrazine compound, and its preparing method and use
12/20/2005US6977305 Modified carbocyanine dyes and their conjugates
12/20/2005US6977302 useful in treatment of fungal infections in humans and other mammals
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor
12/20/2005US6977261 Treating osteoarthritis or rheumatoid arthritis
12/20/2005US6977258 Antiinflammatory agents; cardiotonic agents; rheumatic diseases
12/20/2005CA2233560C Sulfonamide inhibitors of matrix metalloproteinases
12/20/2005CA2176962C N-substituted azabicycloheptane derivatives, their preparation and use
12/20/2005CA2174127C Phenylsulfonyl ureas, processes for their preparation, and their use as herbicides and plant growth regulators
12/20/2005CA2114007C Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
12/15/2005WO2005118587A1 Indole derivative and use for treatment of cancer
12/15/2005WO2005118578A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118575A1 Non nucleoside reverse transcriptase inhibitors
12/15/2005WO2005118574A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118573A1 Novel diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
12/15/2005WO2005118558A2 Pyrimidine compounds and use thereof
12/15/2005WO2005118551A2 Thrombopoietin activity modulating compounds and methods
12/15/2005WO2005118544A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005WO2005118538A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/15/2005WO2005118535A1 Substituted pyrrolidine-2-ones
12/15/2005WO2005117908A2 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases
12/15/2005WO2005102964A3 Porous carbon structures and methods
12/15/2005WO2005087751A3 Substituted hydroxyethylamine aspartyl protease inhibitors
12/15/2005WO2005060571A3 Antiprotozoal imidazopyridine compounds
12/15/2005WO2005017190A3 Mitotic kinesin inhibitors
12/15/2005WO2004098590A8 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/15/2005US20050277686 Benzimidazole compounds for regulating IgE
12/15/2005US20050277685 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders
12/15/2005US20050277683 Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
12/15/2005US20050277674 opioid receptor ligands such as {4-[3-(1H-indol-3-yl)-pyrrolidine-1-yl]-1-phenyl-cyclohexyl}-dimethylamine dihydrochloride salt, used as analgesics
12/15/2005US20050277673 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability
12/15/2005US20050277671 Benzimidazolone carboxylic acid derivatives
12/15/2005US20050277654 4,5-Disubstituted-2-aryl pyrimidines
12/15/2005US20050277653 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277649 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277642 Pyrimidine kinase inhibitors
12/15/2005US20050277640 Pyrimidine derivatives for treatment of hyperproliferative disorders
12/15/2005US20050277638 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005DE19963607B4 Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen Process for the preparation of 4- (heteroaryl-methyl) halo-1 (2H) -phthalazinonen
12/15/2005DE102004024773A1 Substituierte 2,5-Diaminomethyl-1H-pyrrole Substituted 2,5-diaminomethyl-1H-pyrroles
12/15/2005CA2566531A1 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005CA2566187A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005CA2565689A1 Substituted pyrrolidine-2-ones
12/15/2005CA2565280A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005CA2561858A1 Arylsulfonamides and uses related thereto
12/14/2005EP1604989A1 DPP-IV inhibitors
12/14/2005EP1604988A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1603913A1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
12/14/2005EP1603905A1 Vanilloid receptor ligands and their use in treatments
12/14/2005EP1603900A2 Antiprotozoal imidazopyridine compounds
12/14/2005EP1603897A1 Pyrazole compounds useful in the treatment of inflammation
12/14/2005EP1603886A1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors
12/14/2005EP1603885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors
12/14/2005EP1603572A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
12/14/2005EP1603570A2 Aminoheteroaryl compounds as protein kinase inhibitors
12/14/2005EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
12/14/2005EP1222175B1 4,5-disubstituted-2-aminopyrimidines
12/14/2005EP1119562B1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
12/14/2005CN1708560A Beta-isoindigo coloring agent
12/14/2005CN1708495A Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
12/14/2005CN1706824A Compound as CCR5 agonist
12/14/2005CN1231762C Method for directly identifying candidate compound
12/14/2005CN1231479C Naphthostyrils compounds
12/14/2005CN1231473C Substituted arylpyrazines
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/13/2005US6974873 Preferential compound for use as diagnostic tool
12/13/2005US6974869 Piperizinones as modulators of chemokine receptor activity
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/13/2005US6974815 effective as antagonists of Leukointegrins and/or ICAMs
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/12/2005WO2005121110A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/08/2005WO2005116014A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
12/08/2005WO2005116013A1 Crystal of pharmaceutical compound
12/08/2005WO2005115993A1 Quinazoline derivative
12/08/2005WO2005115990A1 Cinnamide compound
12/08/2005WO2005115986A1 Therapeutic compounds: pyridine as scaffold
12/08/2005WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists
12/08/2005WO2005115976A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005WO2005115975A1 Arylalkylamines and process for production thereof
12/08/2005WO2005115398A2 Hiv integrase inhibitors
12/08/2005WO2005115392A2 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005WO2005115384A2 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
12/08/2005WO2005115145A2 Quinone substituted quinazoline and quinoline kinase inhibitors
12/08/2005WO2005090294A3 PROCESS OF MAKING α-AMINOOXYKETONE/α-AMINOOXYALDEHYDE AND α-HYDROXYKETONE/α-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS OF MAKING REACTION PRODUCTS FROM CYCLIC α,ß-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES
12/08/2005WO2005087724A3 Sulphonylpyrroles as hdac inhibitors
12/08/2005WO2005075436A3 Novel inhibitors of glutaminyl cyclase
1 ... 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 ... 626